Board of Directors
Suzanne BeDell joined Elsevier as Managing Director in September 2010. She has been a book publishing and information industry leader for almost 30 years focusing on the intersection of print and digital delivery for much of her career. Prior to joining Elsevier, she worked for ProQuest (a library aggregator) for 9 years where she led the development of the largest offering of aggregated books and journals for academic libraries. Before that, Suzanne was Senior Vice President of Internet Products at Thomson Healthcare and Director of Electronic Product Development for Mosby. She also held a variety of positions in McGraw-Hill’s College Division, including publisher of Primis, the first electronic custom publishing system for textbooks.
Dr. Xuetao Cao is the current President of Chinese Academy of Medical Sciences and Peking Union Medical College. He was born in 1964 and received his both of his M.D. and Ph.D degrees from the Second Military Medical University (1986 and 1990, Shanghai, China). He became Professor in Immunology in 1993 at the Second Military Medical University and the Director of the Institute of Immunology at the same University in 2001. He is the Founder Director of the Institute of Immunology at Zhejiang University since 2000. He has also been Professor and Director of the National Key Laboratory of Medical Immunology since 2006. Dr. Cao was elected to the Chinese Academy of Engineering in 2005, German Academy of Sciences in 2013, French Academy of Medicine in 2014, EMBO in 2015 and UK Academy of Medicine in 2016. He was President of Chinese Society for Immunology for 8 years (2006.10-2014.10), President of Federation of Immunological Societies in Asia and Oceania FIMSA (2012.5-2015.6) and President of Global Alliance for Chronic Diseases GACD (2013.12-2015.12). He is currently the Secretary General of Chinese Society for Immunology (2014.10- ), and Secretary General of FIMSA (2016.6- ).
His laboratory focuses on the understanding of innate signaling in immunity and inflammation, identification of cell subsets and new molecules in dendritic cell (DC)-initiated immune response and cancer immunotherapy. His group has identified important mediators and regulators of innate immune response and inflammation, characterized immune subsets with regulatory function in immunity and cancer. As corresponding author, he has published more than 230 original papers in prestigious peer-reviewed journals such as Cell, Nature, Science, Nature Immunology, Cancer Cell, and Immunity. He is Founder and Editor-in-Chief of Chinese Journal of Cancer Biotherapy, and Editor-in-Chief of Cellular and Molecular Immunology. He also serves on the editorial or advisory board of a number of international journals including Cell, Annual Reviews of Immunology and Science Translational Medicine, ELife, Cell Research.
Dr. Cao has won many awards in recognition of his scientific achievements and dedication to public services and China's medical research and education. He is widely recognized as a thought leader in promoting innovative and cross-disciplinary research at the national level and spearheads a number of initiatives. He is also proud to act as a bridge between China and the world on many occasions and has worked tirelessly to encourage international collaborations and enhance the global visibility of China's own research and development.
YoungSuk ‘YS’ Chi
YoungSuk ‘YS’ Chi is an international businessman and a leader in the media and technology industry, and currently serves Elsevier and RELX Group in several different capacities. In his primary role as head of Corporate Affairs for RELX Group, he is responsible for government affairs, corporate communications, corporate responsibility, and Asia strategy for Elsevier’s parent company. As non-executive Chairman of Elsevier, he works directly with governments, Elsevier customers and in industry associations worldwide. Mr. Chi also serves as President of the International Publishers Association, a global organization that represents the interests of more than 50 publishing industry association members from countries around the world. Early in his career, as Chief Operating Officer of Ingram Book Group, Mr. Chi founded Lightning Source, the first ever print-on-demand distributor and e-book services provider. After holding several senior executive positions at Ingram Book Group’s parent company, he became President and Chief Operating Officer of Random House. Mr. Chi has also earned widespread respect for his ability to work across cultures. As founding Chairman of Random House Asia, he led efforts to make Random House the first foreign trade book publisher with local language publishing in Japan and Korea. Mr. Chi has served on numerous charitable, educational and industry boards, including Princeton University, Korean American Community Foundation and McCarter Theatre. He is also a member of the Executive Committee of the boards of Association of American Publishers and International Association of Scientific, Technical & Medical Publishers.
Dr. John Danaher, Elsevier's President, Clinical Solutions, is a prominent life-long leader and expert in health and the business of health. At Elsevier, he heads the Clinical Solutions business focused on improving patient outcomes through optimizing provider performance and patient engagement. Clinical Solutions is focused on delivering industry leading products focused on improving care at every stage in the patient journey.
Previously he headed Elsevier’s Education business and led the transformation from a traditional publisher to an educational digital solutions provider focused on improving student outcomes. Prior to joining Elsevier, John was President of the Schools of Health Sciences and Nursing at Kaplan. He brings a great depth of experience in digital media in health care and education from his time at Kaplan, Discovery Communications, and as executive vice president of WebMD and part of the early management team. John has deep domain expertise and a successful track-record in managing health information businesses. His experience, in both government and the private sector, extends beyond the US and into global markets, including assignments and experience with Japan, Pakistan, the UK and Australia.
Hannfried von Hindenburg
Hannfried von Hindenburg is a seasoned communications professional with over 20 years of industry expertise spanning work across Asia, the U.S. and Europe. He has held numerous positions in both academia as well as journalism, publishing on international relations issues and appearing as an on-air anchor. Hannfried joined Elsevier in 2015 from the International Finance Corporation, a member of the World Bank Group, based most recently in Hong Kong where he oversaw communications for the Asian region. During his time in Hong Kong and previously in Washington, D.C., Hannfried led initiatives focused on communications strategy, social media, thought leadership, corporate brand and reputation management. Prior to joining IFC, he spent nine years with Reuters in Germany, where he held positions in e-business development, as an editor and as a print and TV reporter in business, finance and economic policy.
Mr. Jinsi heads IFC’s venture capital investment group. He joined IFC in 2003 and combines over 20 years of experience in various industry sectors, having worked and lived in Europe, Asia, Latin America and the US. Mr. Jinsi blends operational, entrepreneurial, investment banking and over 15 years of emerging market private equity experiences with unique global perspective on several industries. At IFC, Mr. Jinsi has led over 18 investments totaling more than US$200 million, for which IFC acted as a (co-)lead and involving other leading private equity and strategic players in Asia, and currently sits on the boards of six Asian companies. Mr. Jinsi also is involved with IFC's LP investment program for venture funds in Asia, having evaluated several fund investment opportunities in China, Vietnam, Indonesia, Singapore and India, and sits on the Advisory Board of a leading (US$500mm) China venture fund, and has been responsible for several fund investments in India. Prior to joining IFC in Washington DC, Mr. Jinsi spent almost nine years living and working in Asia. Mr. Jinsi was the Managing Director and Head of the Singapore office for one of Asia's leading venture funds where he managed the team making investments in South East Asia and India and was also responsible for managing several Asian LP relations. Prior to this, Mr. Jinsi spent 4 years in the Asian investment banking industry providing M&A and corporate finance services to clients throughout the region. In addition, Mr. Jinsi was the co-owner of South East Asia's largest independent marketing communications agency, with offices in Singapore and Kuala Lumpur, which was successfully sold to Omnicom (NYSE:OMC), the largest media marketing group in the world, in 2002. Mr. Jinsi started his career working for KPN Telecom in the Netherlands, working as a Project Manager. Mr. Jinsi obtained an MBA degree from Stanford University (USA), attended as a Fulbright Scholar and an M Sc. degree in Electrical Engineering, from Delft University of Technology, the Netherlands.
Dr. Beverly Malone is currently CEO of the National League for Nursing. Her tenure at the NLN has been marked by a retooling of the League's mission to reflect the core values of caring, diversity, integrity, and excellence and an ongoing focus on advancing the health of the nation and the global community. She was ranked amongst the 100 Most Influential People in Healthcare by Modern Healthcare magazine in 2010 and 2015; in 2016 Dr. Malone moved up the ladder to claim 39th place in the field of leading policy-makers, activists, health care professionals, and corporate figures in the health care, insurance, and pharmaceutical industries. Additional recognition in 2016 includes the Florence Nightingale Award and induction into the Home Care & Hospice Hall of Fame, an honorary doctorate from Georgetown University; and induction into the Nursing Hall of Fame at Tuskegee University in Alabama. Within the last several years, Dr. Malone was elected to the Institute of Medicine and tapped to join the board of the Kaiser Family Foundation.
Dr. Malone served on the Institute of Medicine's Forum on the Future of Nursing Education, contributing to the IOM's groundbreaking report, "The Future of Nursing: Leading Change, Advancing Health," and on the Advisory Committee on Minority Health, a federal panel established to advise the secretary of health and human services. Her distinguished career has mixed policy, education, administration, and clinical practice. Dr. Malone has worked as a surgical staff nurse, clinical nurse specialist, director of nursing, and assistant administrator of nursing. During the 1980s she was dean of the School of Nursing at North Carolina Agricultural and Technical State University. In 1996, she was elected to two terms as president of the American Nurses Association (ANA), representing 180,000 nurses in the USA. In 2000, she became deputy assistant secretary for health within the US Department of Health and Human Services, following four years of service on President Bill Clinton’s Advisory Commission on Consumer Protection and Quality in the Healthcare Industry. Just prior to joining the NLN, Dr. Malone was general secretary of the Royal College of Nursing (RCN), the United Kingdom's largest professional union of nurses, from June 2001 to January 2007. She also served between 2002 and 2006, as a member of the UK delegation to the World Health Assembly; of the Commonwealth Nurses Federation (CNF); and of the Higher Education Funding Council for England (HEFCE). During that time, Dr. Malone was also vice chair of the Brussels-based European Federation of Nurses Association (EFN).
Dr. Emilie Marcus is CEO of Cell Press and Editor-in-Chief of Cell. Emilie has been a major contributor to debates on issues facing scientific publishing. She has served as a panellist on open debates about alternative publishing models at Harvard and Brandeis Universities and on the publishing ethics panel at the 2006 Annual Meeting of the Council of Science Editors. She also is frequently asked to give talks at universities on the editorial process. She championed a new policy, launched in 2005, to make all content in the Cell Press journals – back to 1995 – freely available online 12 months after publication. Emilie is responsible for identifying and promoting new scientific and technological trends that will shape the future of scientific research. Under her editorship, Cell launched a new section called Leading Edge which expands the realm of content in the journal beyond primary research results to include dynamic and interactive commentaries, opinions and debates on global issues and policies that directly affect scientific research. Prior to joining Cell, Emilie had a successful graduate and postdoctoral research career, first at Yale University, where she received her PhD in Biology/Neuroscience in 1993, and then at the Salk Institute and University of California at San Diego. Emilie was also Editor of Neuron from 1998 to 2003. Emilie has also contributed to debate around the value and robustness of the peer-review process, handling potential conflicts of interest for authors, reviewers and editors, scientific misconduct and data manipulation, the impact of new information technologies (blogs, wikis and data and text-mining capabilities), new publishing business models, and the uses and abuses of the impact factor as a measure of journal quality. Read more about Emilie in the March 2013 issue of Elsevier Connect, CEO: Is the Gender Gap a Gender Issue?.
Ron Mobed was appointed Chief Executive Officer, Elsevier in August 2012. Ron previously headed Elsevier’s science and technology businesses. Joining Elsevier in 2011, Ron has had broad range of global experience in electronic information businesses across a number of sectors and regions globally. He was previously President of Cengage Learning's Academic & Professional Group. Earlier, Ron held a series of leadership positions with information services company IHS, including as Co-President & Co-Chief Operating Officer; and with Schlumberger.
Ron is a Fellow of the Institute of Directors and of the Energy Institute. He holds a bachelor's degree in engineering from Trinity College, University of Cambridge and a master's degree in petroleum engineering from Imperial College, University of London.
Cosmas Milton Obote Ochieng
Cosmas Milton Obote Ochieng is an Associate Professor of the Practice of Global Development Policy at the Pardee School of Global Studies, Boston University. His research and teaching interests focus on the theory, policy and practice of development; global climate change and environmental policy; science, technology and innovation policy; and the political economy of African development.
Prior to joining Boston University, Dr. Ochieng served as Executive Director of the African Centre for Technology Studies (ACTS) based in Nairobi, Kenya. He has also served as the Technical Coordinator for the Business, Economics and Biodiversity Program of the International Union for Conservation of Nature (IUCN), Eastern and Southern Africa Regional Office in Pretoria; Climate Change Expert at the UNEP Risoe Centre (Technical University of Denmark); Lecturer in Sustainable Agriculture, Land and Water at Lancaster University in the UK; and Research Fellow, with the International Food Policy Research Institute (IFPRI). He continues to serve on the Board of the Elsevier Foundation and on the Scientific Committee of Future Earth.
Dr. Ochieng was the Lead Author of the inaugural Africa Data Revolution Report (2016). His new book Harnessing Nanotechnology for Sustainable Development in Africa (with Hailemichael Demissie and others) explores the potential applications of technology to sustainable development challenges in Africa. He is also the author of a book on Enhancing Effectiveness of Community Based Adaptation to Climate Change (together with Saleemul Huq and others).
Dr. Ochieng is a graduate of Oxford and Cambridge universities in the UK, and Kenyatta University in Kenya.
Prof. Geraldine Richmond is the Presidential Chair in Science and Professor of Chemistry at the University of Oregon. Her research has relevance to current issues in energy production, environmental remediation and atmospheric chemistry. Her teaching activities in the classroom and beyond focus on science literacy, science policy and building a strong and diverse science and engineering workforce in the U.S. and globally. Throughout her career she has been actively involved in efforts to increase the number and success of women in science and engineering. Richmond is a member of the National Academy of Sciences, the American Academy of Arts and Sciences and is a Fellow of the American Chemical Society (ACS), the American Physical Society (APS), the Association for the Advancement of Science (AAAS) and the Association for Women in Science. Richmond recently finished her term as President of AAAS and is currently the Chair of the Board of AAAS. She is also currently serving as a member of the National Science Board (President Obama appointee. She is the founding and current director of COACh (http://coach.uoregon.edu), a grass-roots organization formed in 1998 that has helped in the career advancement of thousands of scientists and engineers in the U.S., Asia, Africa and Latin America. She is also a member of the Elsevier Foundation (www.elsevierfoundation.org) Board which works to advance diversity in science, research in developing countries and technology for development.